Comparison of first experience with different inhalers in COPD: a cross-over study Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care Year: 2020
Open, randomized, two-way crossover, pilot study to assess the effect of salbutamol in comparison with ipratropium bromide on central and peripheral airway dimensions in COPD patients Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients Year: 2009
A comparative study to evaluate the effects of salmetrol/fluticasone and formoterol/budesonide combinations on lung functions and sleep quality in asthma Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011
A randomized, double blind, cross-over study to investigate the pharmacodynamic equivalence of salbutamol administered via a new HFA134 inhaler versus Evohaler in mild stable asthmatics Source: Eur Respir J 2006; 28: Suppl. 50, 210s Year: 2006
The patterns of inadequate drug administration in children with asthma: a multi-center retrospective study Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002
A randomized, crossover study to examine the pharmacodynamics and safety of a new antimuscarinic (TD-4208) in COPD Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012
The evaluation of the efficacy and safety of phospholipids‘ inhalation in patients with bronchial asthma (BA): A prospective randomized placebo-controlled study Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012
A multicentre, double-blind, double-dummy, randomized, parallel group study to assess efficacy and safety of beclomethasone dipropionate and ease of handling of a breath operated aerosol inhaler in adults with reversible airways obstruction Source: Eur Respir J 2001; 18: Suppl. 33, 101s Year: 2001
For how much time and with which dose of inhaled steroids it is possible to maintain asthma control? A randomized prospective study Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010
Efficacy and safety of montelukast sodium on adult bronchial asthma in a multicentre comparative double-blind clinical study with pranlukast hydrate Source: Eur Respir J 2002; 20: Suppl. 38, 107s Year: 2002
Efficacy and safety of montelukast sodium on adult bronchial asthma in a multicenter comparative double-blind clinical study with pranlukast hydrate Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001
The experience of study of comparative efficiency of seretid, fluticasone and beclametasone at children Source: Eur Respir J 2004; 24: Suppl. 48, 165s Year: 2004
Evaluation of biological quality control variance in a multi-center clinical trial for inhaled insulin Source: Annual Congress 2007 - Quality, sleep and physiology Year: 2007
Efficacy and safety profile of xanthines in COPD: a network meta-analysis Source: Eur Respir Rev, 27 (148) 180010; 10.1183/16000617.0010-2018 Year: 2018
Efficacy and safety profile of xanthines in COPD: a network meta-analysis Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018
Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019
The relation between paracetamol use and asthma: a European case-control study Source: Annual Congress 2008 - Epidemiology of asthma and allergy Year: 2008
A multicenter, open-label, randomized comparison of the effects of HFA-BDP and FP on asthmatic inflammation of lower airways and health-related quality of life Source: Eur Respir J 2007; 30: Suppl. 51, 616s Year: 2007
Double blind, placebo controlled crossover study in COPD patients to assess the acute effect of budesonide/formoterol using HRCT and lung function tests Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Glycopyrrolate MDI demonstrates comparable efficacy and safety to tiotropium DPI in a randomized, double-blind, placebo-controlled phase 2b study in patients with COPD Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011